Your browser doesn't support javascript.
loading
The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green, Heather; Jones, Andrew M.
Afiliação
  • Green H; Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester NHS Trust, Manchester, United Kingdom.
  • Jones AM; Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester NHS Trust, Manchester, United Kingdom.
Semin Respir Crit Care Med ; 36(2): 225-35, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25826590
Chronic pulmonary sepsis is the predominant cause of morbidity for patients with cystic fibrosis (CF) and non-CF bronchiectasis. Previously it was thought that respiratory infection in these patients was mostly limited to a very small number of typical pathogens; however, in recent years there have been increasing reports of infection with other emerging potential pathogens including Burkholderia, Stenotrophomonas, Achromobacter, Ralstonia, Pandoraea, nontuberculous mycobacteria, and fungal species. Furthermore, culture-independent methodologies have established that the lungs of patients with CF and non-CF bronchiectasis comprise mixed microbiological communities of aerobic and anaerobic bacteria, fungal and viral species, collectively referred to as the lung microbiome. This article addresses the clinical relevance of emerging pathogens and the lung microbiome in CF and non-CF bronchiectasis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Bronquiectasia / Fibrose Cística / Microbiota / Pulmão Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Bronquiectasia / Fibrose Cística / Microbiota / Pulmão Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article